BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 10711676)

  • 21. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
    Mitsiades N; Yu WH; Poulaki V; Tsokos M; Stamenkovic I
    Cancer Res; 2001 Jan; 61(2):577-81. PubMed ID: 11212252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
    Liu WH; Cheng YC; Chang LS
    J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High molecular weight plasma proteins induce apoptosis and Fas/FasL expression in human proximal tubular cells.
    Morais C; Westhuyzen J; Metharom P; Healy H
    Nephrol Dial Transplant; 2005 Jan; 20(1):50-8. PubMed ID: 15522900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells.
    Kataoka T; Ito M; Budd RC; Tschopp J; Nagai K
    Exp Cell Res; 2002 Feb; 273(2):256-64. PubMed ID: 11822881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.
    Brás A; Albar JP; Leonardo E; de Buitrago GG; Martínez-A C
    Cell Death Differ; 2000 Mar; 7(3):262-71. PubMed ID: 10745271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells.
    Glotin AL; Calipel A; Brossas JY; Faussat AM; Tréton J; Mascarelli F
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4614-23. PubMed ID: 17003459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway.
    Liu WH; Chang LS
    Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis.
    Bühling F; Wille A; Röcken C; Wiesner O; Baier A; Meinecke I; Welte T; Pap T
    Respir Res; 2005 Apr; 6(1):37. PubMed ID: 15833141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling.
    Margalit KA; Cowan RG; Harman RM; Quirk SM
    Reproduction; 2005 Nov; 130(5):751-8. PubMed ID: 16264104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
    Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis.
    Martin JH; Potthoff A; Ledig S; Cornberg M; Jandl O; Manns MP; Kubicka S; Flemming P; Athmann C; Beil W; Wagner S
    Helicobacter; 2004 Oct; 9(5):371-86. PubMed ID: 15361075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells.
    Petak I; Tillman DM; Harwood FG; Mihalik R; Houghton JA
    Cancer Res; 2000 May; 60(10):2643-50. PubMed ID: 10825136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-1beta sensitizes rat intervertebral disc cells to Fas ligand mediated apoptosis in vitro.
    Cui LY; Liu SL; Ding Y; Huang DS; Ma RF; Huang WG; Hu BS; Pan QH
    Acta Pharmacol Sin; 2007 Oct; 28(10):1671-6. PubMed ID: 17883956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis.
    Caricchio R; Reap EA; Cohen PL
    J Immunol; 1998 Jul; 161(1):241-51. PubMed ID: 9647230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesangial cell Fas ligand: upregulation in human lupus nephritis and NF-kappaB-mediated expression in cultured human mesangial cells.
    Tsukinoki T; Sugiyama H; Sunami R; Kobayashi M; Onoda T; Maeshima Y; Yamasaki Y; Makino H
    Clin Exp Nephrol; 2004 Sep; 8(3):196-205. PubMed ID: 15480896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.